Cargando…

Identification of triptonide as a therapeutic agent for triple negative breast cancer treatment

Triple-negative breast cancer (TNBC) is associated with a high rate of early recurrence and distant metastasis, frequent development of therapeutic resistance, and a poor prognosis. There is a lack of targeted therapies for this aggressive subtype of breast cancer. Identifying novel effective treatm...

Descripción completa

Detalles Bibliográficos
Autores principales:	Gao, Bowen, Chen, Jiongyu, Han, Bingchen, Zhang, Xinfeng, Hao, Jijun, Giuliano, Armando E., Cui, Yukun, Cui, Xiaojiang
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7843598/ https://www.ncbi.nlm.nih.gov/pubmed/33510281 http://dx.doi.org/10.1038/s41598-021-82128-0

Ejemplares similares

Breast cancer lung metastasis: Molecular biology and therapeutic implications
por: Jin, Liting, et al.
Publicado: (2018)

FOXC1-Induced Non-Canonical WNT5A-MMP7 Signaling Regulates Invasiveness in Triple-Negative Breast Cancer
por: Han, Bingchen, et al.
Publicado: (2017)

Triptonide effectively inhibits triple-negative breast cancer metastasis through concurrent degradation of Twist1 and Notch1 oncoproteins
por: Zhang, Mengli, et al.
Publicado: (2021)

Identification of EGF-NF-κB-FOXC1 signaling axis in basal-like breast cancer
por: Chung, Stacey, et al.
Publicado: (2017)

A chemokine regulatory loop induces cholesterol synthesis in lung-colonizing triple-negative breast cancer cells to fuel metastatic growth
por: Han, Bingchen, et al.
Publicado: (2022)

Triptonide Effectively Inhibits Wnt/β-Catenin Signaling via C-terminal Transactivation Domain of β-catenin
por: Chinison, Jessica, et al.
Publicado: (2016)

FOXC1: an emerging marker and therapeutic target for cancer
por: Han, Bingchen, et al.
Publicado: (2017)

Triptonide is a reversible non-hormonal male contraceptive agent in mice and non-human primates
por: Chang, Zongliang, et al.
Publicado: (2021)

Tripterygium wilfordii cytochrome P450s catalyze the methyl shift and epoxidations in the biosynthesis of triptonide
por: Hansen, Nikolaj Lervad, et al.
Publicado: (2022)

TOP1 inhibition induces bifurcated JNK/MYC signaling that dictates cancer cell sensitivity
por: Liu, Qizhi, et al.
Publicado: (2022)

Stratification of Prognosis of Triple-Negative Breast Cancer Patients Using Combinatorial Biomarkers
por: Yue, Yong, et al.
Publicado: (2016)

Triptonide inhibits metastasis potential of thyroid cancer cells via astrocyte elevated gene-1
por: Fu, Liangjie, et al.
Publicado: (2020)

Ceritinib is a novel triple negative breast cancer therapeutic agent
por: Dong, Shengli, et al.
Publicado: (2022)

Differentiation of Human Induced Pluripotent Stem Cells to Mammary-like Organoids
por: Qu, Ying, et al.
Publicado: (2017)

Ferroptosis and triple-negative breast cancer: Potential therapeutic targets
por: Xu, Na, et al.
Publicado: (2022)

Disabling the Nuclear Translocalization of RelA/NF-κB by a Small Molecule Inhibits Triple-Negative Breast Cancer Growth
por: Kanzaki, Hirotaka, et al.
Publicado: (2021)

Inhibition of lobuloalveolar development by FOXC1 overexpression in the mouse mammary gland
por: Gao, Bowen, et al.
Publicado: (2017)

Stratifying triple-negative breast cancer prognosis using 18F-FDG-PET/CT imaging
por: Yue, Yong, et al.
Publicado: (2015)

The therapeutic and prognostic role of cuproptosis-related genes in triple negative breast cancer
por: Shi, Bingye, et al.
Publicado: (2023)

Intravenous Administration of Triptonide Attenuates CFA-Induced Pain Hypersensitivity by Inhibiting DRG AKT Signaling Pathway in Mice
por: Ling, Yue-Juan, et al.
Publicado: (2020)

FOXC1 identifies basal-like breast cancer in a hereditary breast cancer cohort
por: Johnson, Jeff, et al.
Publicado: (2016)

Identification of three subtypes of triple-negative breast cancer with potential therapeutic implications
por: Jézéquel, Pascal, et al.
Publicado: (2019)

Stemness signature and targeted therapeutic drugs identification for Triple Negative Breast Cancer
por: Gul, Samina, et al.
Publicado: (2023)

Nomogram for Predicting Lymph Node Involvement in Triple-Negative Breast Cancer
por: Cui, Xiang, et al.
Publicado: (2020)

Current Status of Breast Organoid Models
por: Mohan, Srivarshini Cherukupalli, et al.
Publicado: (2021)

Evaluation of MCF10A as a Reliable Model for Normal Human Mammary Epithelial Cells
por: Qu, Ying, et al.
Publicado: (2015)

Identification of CDC25 as a Common Therapeutic Target for Triple-Negative Breast Cancer
por: Liu, Jeff C., et al.
Publicado: (2018)

Forkhead box C1 boosts triple‐negative breast cancer metastasis through activating the transcription of chemokine receptor‐4
por: Pan, Hongchao, et al.
Publicado: (2018)

Identification of CXCR4 and CXCL10 as Potential Predictive Biomarkers in Triple Negative Breast Cancer (TNBC)
por: Chuan, Tian, et al.
Publicado: (2020)

A Prognostic Model of Triple-Negative Breast Cancer Based on miR-27b-3p and Node Status
por: Shen, Songjie, et al.
Publicado: (2014)

Triple-Negative Breast Cancer: Adjuvant Therapeutic Options
por: Gucalp, Ayca, et al.
Publicado: (2011)

Therapeutic landscape in mutational triple negative breast cancer
por: Shi, Yaqin, et al.
Publicado: (2018)

Targeted Therapeutic Strategies for Triple-Negative Breast Cancer
por: Li, Ying, et al.
Publicado: (2021)

Triptonide Modulates MAPK Signaling Pathways and Exerts Anticancer Effects via ER Stress-Mediated Apoptosis Induction in Human Osteosarcoma Cells
por: Zheng, Liyun, et al.
Publicado: (2020)

Identification of potential core genes in triple negative breast cancer using bioinformatics analysis
por: Li, Man-Xiu, et al.
Publicado: (2018)

Current Status of Poly(ADP-ribose) Polymerase Inhibitors as Novel Therapeutic Agents for Triple-Negative Breast Cancer
por: Hiller, David J., et al.
Publicado: (2012)

LHRH-Conjugated Drugs as Targeted Therapeutic Agents for the Specific Targeting and Localized Treatment of Triple Negative Breast Cancer
por: Obayemi, J. D., et al.
Publicado: (2020)

Transcriptome and proteome characterization of surface ectoderm cells differentiated from human iPSCs
por: Qu, Ying, et al.
Publicado: (2016)

Characterization of primary human mammary epithelial cells isolated and propagated by conditional reprogrammed cell culture
por: Jin, Liting, et al.
Publicado: (2017)

Therapeutic Strategies for Metastatic Triple-Negative Breast Cancers: From Negative to Positive
por: Nandini, Dey, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_305imepb1l64vptglgdfr575ii